MGB Health Plan No Longer Covers Dana-Farber for Medicare Advantage Members

Mass General Brigham's health plan has dropped in-network coverage of Dana-Farber Cancer Institute for its Medicare Advantage members, according to a report published by Healthcare Dive on September 8, 2026. Mass General Brigham (MGB) is a large Boston-based health system, and Dana-Farber Cancer Institute is a major cancer treatment and research center that has operated a decades-long clinical partnership with MGB. Healthcare Dive reports the contract lapse coincides with the two organizations winding down that longstanding relationship.

For Medicare beneficiaries enrolled in an MGB Medicare Advantage (MA) plan, particularly anyone receiving cancer treatment at Dana-Farber, this network change is worth understanding now rather than after a claim is denied. Medicare Advantage is a private-insurer alternative to Original Medicare that typically restricts coverage to a defined network of doctors and hospitals, and losing a major cancer center from that network can directly affect where a member can receive treatment at in-network cost-sharing.

Why a Network Drop Matters More for Cancer Care

Losing access to a specialized cancer center is different from losing a general practitioner. Dana-Farber has historically treated patients alongside Brigham and Women's Hospital through the affiliated Dana-Farber Brigham Cancer Center, so patients already mid-treatment could face a choice between switching oncologists or paying out-of-network rates. The Healthcare Dive report does not specify an effective date for the network change or how many MGB Medicare Advantage members are affected, so beneficiaries should confirm current details directly with their plan rather than assume a timeline.

It's also unclear from the available reporting whether this change affects only Medicare Advantage products or extends to MGB's commercial plans as well; the Healthcare Dive headline and description specifically reference MA coverage. Readers should treat this as a single insurer-provider network change tied to one Boston-area health system relationship, not a broader signal about Medicare Advantage network stability nationwide.

What Losing an In-Network Provider Does, and Doesn't, Trigger

Losing access to a specific hospital or cancer center is generally not, by itself, a qualifying event for a Medicare Advantage Special Enrollment Period (SEP). The Centers for Medicare & Medicaid Services (CMS) is the federal agency that administers Medicare enrollment rules, and its standard SEP list is built around events like moving out of a plan's service area, losing other coverage, or qualifying for Medicaid, not a single provider leaving a network. That means an MGB Medicare Advantage member who wants to switch plans specifically because of the Dana-Farber network change will typically need to wait for the Medicare Annual Enrollment Period, which runs October 15 through December 7, 2026, or, if already enrolled in an MA plan, the Medicare Advantage Open Enrollment Period from January 1 through March 31, 2026 (or January 1 through March 31, 2027 for the following year).

Key Takeaway

If you're an MGB Medicare Advantage member receiving care at Dana-Farber, call your plan directly to confirm whether Dana-Farber is still in-network for your specific plan and what the effective date of any change is. Losing an in-network cancer center is usually not a qualifying event for an off-cycle switch, so most members will need to wait for the Annual Enrollment Period (October 15 to December 7, 2026) or the Medicare Advantage Open Enrollment Period (January 1 to March 31) to change plans.

Steps to Take Before the Annual Enrollment Period

Beneficiaries affected by this or any similar network change should take a few concrete steps rather than waiting until enrollment season arrives. First, contact the health plan's member services line and ask, in writing if possible, whether Dana-Farber Cancer Institute is in-network under the specific plan on the member's card, since MGB may offer multiple MA products with different provider networks. Second, ask the treating oncology team at Dana-Farber whether they can confirm current coverage status for Medicare Advantage patients, since provider offices often track insurer contract changes closely. Third, review the plan's Evidence of Coverage document, which every MA plan must issue and which spells out network terms and any transition-of-care provisions for members already in active treatment.

Anyone considering a switch during the Annual Enrollment Period or the Medicare Advantage Open Enrollment Period should compare not just monthly premiums but which plans in their area include Dana-Farber, Brigham and Women's Hospital, or other preferred specialists in-network for 2027. Original Medicare, by contrast, is generally accepted by any provider that accepts Medicare nationwide, which is a relevant comparison point for beneficiaries whose treatment depends on a specific specialist or cancer center. Because network terms, star ratings, and drug formularies change every year, comparing plans annually, ideally with help from a licensed Medicare agent or the State Health Insurance Assistance Program (SHIP), remains the most reliable way to confirm that a preferred provider is actually covered before committing to a plan for the coming year.